Ziv Beckerman1, Bradley G Leshnower1, LaRonica McPherson1, Jose N Binongo2, Yi Lasanajak2, Edward P Chen1. 1. Division of Cardiothoracic Surgery, Department of Surgery, Rollins School of Public Health, Emory University School of Medicine, Atlanta, GA, USA. 2. Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University School of Medicine, Atlanta, GA, USA.
Abstract
BACKGROUND: Biologic valved-conduits avoids the need for anticoagulation and can exploit the excellent hemodynamic performance of stentless valves. Incorporation of the sinuses of Valsalva into the neoaortic root can improve the function and longevity of stentless valves. We report our experience in performing the Bentall procedure with a self-prefabricated composite valved-conduit and review the published experience with the Valsalva graft. METHODS: From Feb 2005 through Sep 2017, 428 patients underwent aortic root replacement utilizing a composite graft constructed from a 27-29-mm Freestyle MS valve (Medtronic) sutured into a 28-30-mm Gelweave Valsalva prosthesis (Sulzer Vascutek, Renfrewshire, Scotland). Data were retrospectively analyzed. RESULTS: Mean age was 58±13 years, with a male predominance (337, 79%). Additional surgical procedures included a mitral valve repair/replacement in 10 patients (2%), coronary artery bypass graft (CABG) in 114 patients (27%), and aortic arch (hemi or total) replacement in 252 patients (59%). Average cardiopulmonary bypass, cross-clamp, and circulatory arrest times were 210±57, 180±44, and 29±15 min, respectively. Thirty-day mortality was 7% (31 patients). Mean echocardiography follow-up was 27.2±29.0 months (range, 1-138 months). Pressure gradients (mean, peak) across the aortic valve on latest echocardiography were 5.59, 10.57 mmHg respectively. Freedom from >2+ aortic insufficiency (AI) at 6 and 9 years was 96%, and 87% respectively. Freedom from aortic valve replacement (AVR) at 6 and 9 years was 99%, and 95% respectively. To date, 4 (1%) patients required an additional aortic valve intervention secondary to structural valve degeneration. CONCLUSIONS: Use of the Valsalva graft combined with the Freestyle valve for Bentall procedures is associated with favorable results. Clinical outcomes are excellent and in longitudinal follow-up, valve-related complications are minimal.
BACKGROUND: Biologic valved-conduits avoids the need for anticoagulation and can exploit the excellent hemodynamic performance of stentless valves. Incorporation of the sinuses of Valsalva into the neoaortic root can improve the function and longevity of stentless valves. We report our experience in performing the Bentall procedure with a self-prefabricated composite valved-conduit and review the published experience with the Valsalva graft. METHODS: From Feb 2005 through Sep 2017, 428 patients underwent aortic root replacement utilizing a composite graft constructed from a 27-29-mm Freestyle MS valve (Medtronic) sutured into a 28-30-mm Gelweave Valsalva prosthesis (Sulzer Vascutek, Renfrewshire, Scotland). Data were retrospectively analyzed. RESULTS: Mean age was 58±13 years, with a male predominance (337, 79%). Additional surgical procedures included a mitral valve repair/replacement in 10 patients (2%), coronary artery bypass graft (CABG) in 114 patients (27%), and aortic arch (hemi or total) replacement in 252 patients (59%). Average cardiopulmonary bypass, cross-clamp, and circulatory arrest times were 210±57, 180±44, and 29±15 min, respectively. Thirty-day mortality was 7% (31 patients). Mean echocardiography follow-up was 27.2±29.0 months (range, 1-138 months). Pressure gradients (mean, peak) across the aortic valve on latest echocardiography were 5.59, 10.57 mmHg respectively. Freedom from >2+ aortic insufficiency (AI) at 6 and 9 years was 96%, and 87% respectively. Freedom from aortic valve replacement (AVR) at 6 and 9 years was 99%, and 95% respectively. To date, 4 (1%) patients required an additional aortic valve intervention secondary to structural valve degeneration. CONCLUSIONS: Use of the Valsalva graft combined with the Freestyle valve for Bentall procedures is associated with favorable results. Clinical outcomes are excellent and in longitudinal follow-up, valve-related complications are minimal.
Authors: John-Peder Escobar Kvitting; Tino Ebbers; Lars Wigström; Jan Engvall; Christian L Olin; Ann F Bolger Journal: J Thorac Cardiovasc Surg Date: 2004-06 Impact factor: 5.209
Authors: Roberto Di Bartolomeo; Davide Pacini; Sofia Martin-Suarez; Antonino Loforte; Andrea Dell'amore; Marinella Ferlito; Giovanni Bracchetti; Giuseppe Bozzetti Journal: Interact Cardiovasc Thorac Surg Date: 2006-03-02
Authors: Jan D Galla; Steven L Lansman; David Spielvogel; Oktavijan P Minanov; M Arisan Ergin; Carol A Bodian; Randall B Griepp Journal: Ann Thorac Surg Date: 2002-11 Impact factor: 4.330
Authors: Michael E Halkos; Faraz Kerendi; Richard Myung; Patrick Kilgo; John D Puskas; Edward P Chen Journal: J Thorac Cardiovasc Surg Date: 2009-09-15 Impact factor: 5.209
Authors: Clément Dubost; Jacques Tomasi; Antoine Ducroix; Kevin Pluchon; Pierre Escrig; Olivier Fouquet; Arthur Aupart; Alain Mirza; Imen Fellah; Eric Bezon; Christophe Baufreton; Jean Marc El Arid; Jean-Christian Roussel; Jean-Philippe Verhoye; Thomas Senage Journal: Interact Cardiovasc Thorac Surg Date: 2022-10-10